Pain study pulled before it even started
NCT ID NCT04756791
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to compare two ways of numbing the chest after a mastectomy: a targeted nerve block versus direct injection into the surgical area. It was planned for adults aged 18-80 undergoing unilateral mastectomy. However, the trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ropivacaine
- What this could lead to
- If it had succeeded, this could have pointed to a better way to manage pain after mastectomy, possibly reducing opioid use.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no data exist. Even if run, it was a small, early comparison with uncertain real-world benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UZ Brussel
Jette, Brussels Capital, 1090, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?